BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 20087334)

  • 1. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis.
    Yaghoobi M; Farrokhyar F; Yuan Y; Hunt RH
    Am J Gastroenterol; 2010 May; 105(5):1007-13; quiz 1006, 1014. PubMed ID: 20087334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
    Fallone CA; Barkun AN; Friedman G; Mayrand S; Loo V; Beech R; Best L; Joseph L
    Am J Gastroenterol; 2000 Apr; 95(4):914-20. PubMed ID: 10763937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.
    Laine L; Sugg J
    Am J Gastroenterol; 2002 Dec; 97(12):2992-7. PubMed ID: 12492181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials.
    Saad AM; Choudhary A; Bechtold ML
    Scand J Gastroenterol; 2012 Feb; 47(2):129-35. PubMed ID: 22229305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
    Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Helicobacter pylori eradication and gastroesophageal reflux disease: a Meta-analysis].
    Wang XT; Zhang M; Chen CY; Lyu B
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):710-6. PubMed ID: 27586980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
    Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased body mass index after H. pylori eradication for duodenal ulcer predisposes to erosive reflux esophagitis.
    Yang YJ; Sheu BS; Chang WL; Cheng HC; Yang HB
    J Clin Gastroenterol; 2009 Sep; 43(8):705-10. PubMed ID: 19398924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms.
    Nam SY; Choi IJ; Ryu KH; Kim BC; Kim CG; Nam BH
    Am J Gastroenterol; 2010 Oct; 105(10):2153-62. PubMed ID: 20571493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of Helicobacter pylori infection in patients with reflux esophagitis. A case-control study].
    Carmona-Sánchez R; Navarro-Cano G
    Rev Gastroenterol Mex; 2003; 68(1):23-8. PubMed ID: 12940095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
    Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
    Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease.
    Xie T; Cui X; Zheng H; Chen D; He L; Jiang B
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1195-205. PubMed ID: 23839160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    Bianchi Porro G; Lazzaroni M; Bargiggia S; Maconi G; Trespi E; Perego M; Alvisi C; Villani L; Luinetti O; Fiocca R; Franceschi M; Cesana B; Solcia E
    Am J Gastroenterol; 1996 Apr; 91(4):695-700. PubMed ID: 8677931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
    El-Serag HB; Graham DY; Satia JA; Rabeneck L
    Am J Gastroenterol; 2005 Jun; 100(6):1243-50. PubMed ID: 15929752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
    Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
    Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
    Ott EA; Mazzoleni LE; Edelweiss MI; Sander GB; Wortmann AC; Theil AL; Somm G; Cartell A; Rivero LF; Uchôa DM; Francesconi CF; Prolla JC
    Aliment Pharmacol Ther; 2005 May; 21(10):1231-9. PubMed ID: 15882244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Helicobacter pylori infection explain all socio-economic differences in peptic ulcer incidence? Genetic and psychosocial markers for incident peptic ulcer disease in a large cohort of Danish adults.
    Rosenstock SJ; Jørgensen T; Bonnevie O; Andersen LP
    Scand J Gastroenterol; 2004 Sep; 39(9):823-9. PubMed ID: 15513379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.